Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page shows a new revision label v3.6.3, replacing the previous v3.6.0. This indicates an update to the page version, but does not alter the study details or results.
    Difference
    0.0%
    Check dated 2026-06-30T03:22:24.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    New navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header was added while the Intervention / Treatment header formatting was removed, with the revision label updated from v3.5.5 to v3.6.0. Additionally, the page now displays 'No longer looking for participants,' indicating that enrollment has ended.
    Difference
    0.1%
    Check dated 2026-06-16T00:00:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The site’s revision metadata was updated from v3.5.4 to v3.5.5, signaling a new build of the page template. This update does not change the study data or content on the page.
    Difference
    0.0%
    Check dated 2026-06-08T23:07:48.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study location listing for Kharkiv has been updated from Kharkivs’ka Oblast’ and the old city/address line to Kharkiv Oblast and Kharkiv, Kharkiv Oblast, Ukraine, 61024.
    Difference
    0.0%
    Check dated 2026-06-01T19:22:44.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    A new PubMed citation about patient-reported outcomes from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial has been added to the Publications section. A note clarifies that these publications are automatically filled from PubMed and may not all be about the study.
    Difference
    0.1%
    Check dated 2026-05-25T16:41:07.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the study record page.
    Difference
    0.0%
    Check dated 2026-05-18T13:01:17.000Z thumbnail image

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.